Professor Shuji Ogino

Shuji is the founding Chief of the Molecular Pathological Epidemiology (MPE) Program, Brigham and Women’s Hospital; Professor of Pathology at Harvard Medical School; Professor of Epidemiology at Harvard T.H. Chan School of Public Health; Associate Member of the Broad Institute of MIT and Harvard and a Member of the DFHCC Cancer Immunology Program. 

Shuji established the International MPE Meeting Series in 2013 and has been serving as its Chair/Co-Chair.  He spearheads the integrative science of MPE, to study the interactive roles of environment (i.e. the exposome), microbiome, immunity, and tumour in carcinogenesis.  He conducts multifaceted MPE studies using large-scale prospective cohort studies, having discovered the link between fiber-poor / inflammatory diet and higher incidence of colorectal cancer enriched with Fusobacterium nucleatum as well as evidence for suppressive effect of F. nucleatum on T-cell-mediated antitumor immunity.  For his unique transdisciplinary scientific contribution, Dr. Ogino has received many awards and honours.